0001104659-24-097065.txt : 20240904 0001104659-24-097065.hdr.sgml : 20240904 20240904215812 ACCESSION NUMBER: 0001104659-24-097065 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240831 FILED AS OF DATE: 20240904 DATE AS OF CHANGE: 20240904 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FISCHER JOST CENTRAL INDEX KEY: 0001366841 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40021 FILM NUMBER: 241279728 MAIL ADDRESS: STREET 1: C/O AEON BIOPHARMA, INC. STREET 2: 4040 MACARTHUR BOULEVARD, SUITE 250 CITY: NEWPORT BEACH STATE: CA ZIP: 92660 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AEON Biopharma, Inc. CENTRAL INDEX KEY: 0001837607 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 853940478 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 PARK PLAZA STREET 2: SUITE 1750 CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: (949) 354-6499 MAIL ADDRESS: STREET 1: 5 PARK PLAZA STREET 2: SUITE 1750 CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: Priveterra Acquisition Corp. DATE OF NAME CHANGE: 20201222 4 1 tm2423415-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-08-31 0 0001837607 AEON Biopharma, Inc. AEON 0001366841 FISCHER JOST 5 PARK PLAZA, SUITE 1750 IRVINE CA 92614 1 0 0 0 0 Class A Common Stock 2024-08-31 4 A 0 36021 0 A 96785 D Stock Option 0.83 2024-08-31 4 A 0 96210 0 A 2034-08-30 Class A Common Stock 96210 96210 D Represents an award of restricted stock units granted on August 31, 2024 (the "Grant Date"), which vests in full on the second anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date. Includes multiple awards of restricted stock units ("RSUs") in the amounts of 19,286, 6,289, and 35,189 previously granted on April 26, 2023, which were previously reported on July 24, 2023 as derivative securities in Table II due to a clerical error, and which are now being reported as common stock in Table I. The vesting terms for the RSUs have not changed from what was previously reported on July 24, 2023. Represents an award of stock options granted on August 31, 2024 (the "Grant Date"), which vest and become exercisable in substantially equal monthly installments over the eighteen months following the Grant Date, subject to the reporting person's continued service through the applicable vesting date. /s/ Alexander Wilson as attorney-in-fact for Jost Fischer 2024-09-04